nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—Cytarabine—lymphatic system cancer	0.102	0.318	CbGbCtD
Tiagabine—CYP3A4—Teniposide—lymphatic system cancer	0.101	0.313	CbGbCtD
Tiagabine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0704	0.219	CbGbCtD
Tiagabine—CYP3A4—Vincristine—lymphatic system cancer	0.0485	0.151	CbGbCtD
Tiagabine—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000968	0.00143	CcSEcCtD
Tiagabine—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000964	0.00142	CcSEcCtD
Tiagabine—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000961	0.00142	CcSEcCtD
Tiagabine—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.000961	0.00142	CcSEcCtD
Tiagabine—Anaemia—Bleomycin—lymphatic system cancer	0.00096	0.00142	CcSEcCtD
Tiagabine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000953	0.0014	CcSEcCtD
Tiagabine—Asthenia—Teniposide—lymphatic system cancer	0.000944	0.00139	CcSEcCtD
Tiagabine—Cystitis noninfective—Methotrexate—lymphatic system cancer	0.000938	0.00138	CcSEcCtD
Tiagabine—Melaena—Methotrexate—lymphatic system cancer	0.000938	0.00138	CcSEcCtD
Tiagabine—Malaise—Bleomycin—lymphatic system cancer	0.000936	0.00138	CcSEcCtD
Tiagabine—Pruritus—Teniposide—lymphatic system cancer	0.000931	0.00137	CcSEcCtD
Tiagabine—Leukopenia—Bleomycin—lymphatic system cancer	0.00093	0.00137	CcSEcCtD
Tiagabine—Cystitis—Methotrexate—lymphatic system cancer	0.000927	0.00137	CcSEcCtD
Tiagabine—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.000927	0.00137	CcSEcCtD
Tiagabine—Alopecia—Carmustine—lymphatic system cancer	0.00092	0.00136	CcSEcCtD
Tiagabine—Body temperature increased—Fludarabine—lymphatic system cancer	0.000914	0.00135	CcSEcCtD
Tiagabine—Vaginal infection—Methotrexate—lymphatic system cancer	0.000907	0.00134	CcSEcCtD
Tiagabine—Cough—Bleomycin—lymphatic system cancer	0.000906	0.00134	CcSEcCtD
Tiagabine—Diarrhoea—Teniposide—lymphatic system cancer	0.0009	0.00133	CcSEcCtD
Tiagabine—Chest pain—Bleomycin—lymphatic system cancer	0.000884	0.0013	CcSEcCtD
Tiagabine—Myalgia—Bleomycin—lymphatic system cancer	0.000884	0.0013	CcSEcCtD
Tiagabine—Alopecia—Vincristine—lymphatic system cancer	0.000878	0.0013	CcSEcCtD
Tiagabine—Coma—Methotrexate—lymphatic system cancer	0.000878	0.00129	CcSEcCtD
Tiagabine—Back pain—Carmustine—lymphatic system cancer	0.000877	0.00129	CcSEcCtD
Tiagabine—Discomfort—Bleomycin—lymphatic system cancer	0.000874	0.00129	CcSEcCtD
Tiagabine—Chills—Mitoxantrone—lymphatic system cancer	0.000869	0.00128	CcSEcCtD
Tiagabine—Urine output increased—Methotrexate—lymphatic system cancer	0.000868	0.00128	CcSEcCtD
Tiagabine—Neoplasm—Methotrexate—lymphatic system cancer	0.000868	0.00128	CcSEcCtD
Tiagabine—Bladder pain—Methotrexate—lymphatic system cancer	0.000868	0.00128	CcSEcCtD
Tiagabine—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000868	0.00128	CcSEcCtD
Tiagabine—Ecchymosis—Methotrexate—lymphatic system cancer	0.000868	0.00128	CcSEcCtD
Tiagabine—Alopecia—Mitoxantrone—lymphatic system cancer	0.000855	0.00126	CcSEcCtD
Tiagabine—Confusional state—Bleomycin—lymphatic system cancer	0.000855	0.00126	CcSEcCtD
Tiagabine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000852	0.00126	CcSEcCtD
Tiagabine—Tremor—Carmustine—lymphatic system cancer	0.000849	0.00125	CcSEcCtD
Tiagabine—Oedema—Bleomycin—lymphatic system cancer	0.000848	0.00125	CcSEcCtD
Tiagabine—Infection—Bleomycin—lymphatic system cancer	0.000842	0.00124	CcSEcCtD
Tiagabine—Anaemia—Carmustine—lymphatic system cancer	0.000838	0.00124	CcSEcCtD
Tiagabine—Back pain—Vincristine—lymphatic system cancer	0.000837	0.00123	CcSEcCtD
Tiagabine—Vomiting—Teniposide—lymphatic system cancer	0.000836	0.00123	CcSEcCtD
Tiagabine—Sepsis—Methotrexate—lymphatic system cancer	0.000833	0.00123	CcSEcCtD
Tiagabine—Agitation—Carmustine—lymphatic system cancer	0.000833	0.00123	CcSEcCtD
Tiagabine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00083	0.00122	CcSEcCtD
Tiagabine—Asthenia—Fludarabine—lymphatic system cancer	0.000829	0.00122	CcSEcCtD
Tiagabine—Rash—Teniposide—lymphatic system cancer	0.000829	0.00122	CcSEcCtD
Tiagabine—Dermatitis—Teniposide—lymphatic system cancer	0.000829	0.00122	CcSEcCtD
Tiagabine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000825	0.00122	CcSEcCtD
Tiagabine—Headache—Teniposide—lymphatic system cancer	0.000824	0.00121	CcSEcCtD
Tiagabine—Pruritus—Fludarabine—lymphatic system cancer	0.000818	0.00121	CcSEcCtD
Tiagabine—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000817	0.0012	CcSEcCtD
Tiagabine—Back pain—Mitoxantrone—lymphatic system cancer	0.000815	0.0012	CcSEcCtD
Tiagabine—Leukopenia—Carmustine—lymphatic system cancer	0.000811	0.0012	CcSEcCtD
Tiagabine—Anorexia—Bleomycin—lymphatic system cancer	0.000808	0.00119	CcSEcCtD
Tiagabine—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000805	0.00119	CcSEcCtD
Tiagabine—Anaemia—Vincristine—lymphatic system cancer	0.0008	0.00118	CcSEcCtD
Tiagabine—Agitation—Vincristine—lymphatic system cancer	0.000795	0.00117	CcSEcCtD
Tiagabine—Polyuria—Methotrexate—lymphatic system cancer	0.000794	0.00117	CcSEcCtD
Tiagabine—Hypotension—Bleomycin—lymphatic system cancer	0.000792	0.00117	CcSEcCtD
Tiagabine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000791	0.00117	CcSEcCtD
Tiagabine—Hypertension—Carmustine—lymphatic system cancer	0.000783	0.00115	CcSEcCtD
Tiagabine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000782	0.00115	CcSEcCtD
Tiagabine—Nausea—Teniposide—lymphatic system cancer	0.000781	0.00115	CcSEcCtD
Tiagabine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000779	0.00115	CcSEcCtD
Tiagabine—Vertigo—Vincristine—lymphatic system cancer	0.000777	0.00115	CcSEcCtD
Tiagabine—Leukopenia—Vincristine—lymphatic system cancer	0.000775	0.00114	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000772	0.00114	CcSEcCtD
Tiagabine—Chest pain—Carmustine—lymphatic system cancer	0.000772	0.00114	CcSEcCtD
Tiagabine—Myalgia—Carmustine—lymphatic system cancer	0.000772	0.00114	CcSEcCtD
Tiagabine—Anxiety—Carmustine—lymphatic system cancer	0.000769	0.00113	CcSEcCtD
Tiagabine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000761	0.00112	CcSEcCtD
Tiagabine—Malaise—Mitoxantrone—lymphatic system cancer	0.00076	0.00112	CcSEcCtD
Tiagabine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000756	0.00111	CcSEcCtD
Tiagabine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000754	0.00111	CcSEcCtD
Tiagabine—Hypertension—Vincristine—lymphatic system cancer	0.000747	0.0011	CcSEcCtD
Tiagabine—Confusional state—Carmustine—lymphatic system cancer	0.000746	0.0011	CcSEcCtD
Tiagabine—Oedema—Carmustine—lymphatic system cancer	0.00074	0.00109	CcSEcCtD
Tiagabine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000739	0.00109	CcSEcCtD
Tiagabine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000737	0.00109	CcSEcCtD
Tiagabine—Myalgia—Vincristine—lymphatic system cancer	0.000737	0.00109	CcSEcCtD
Tiagabine—Cough—Mitoxantrone—lymphatic system cancer	0.000735	0.00108	CcSEcCtD
Tiagabine—Infection—Carmustine—lymphatic system cancer	0.000735	0.00108	CcSEcCtD
Tiagabine—Vomiting—Fludarabine—lymphatic system cancer	0.000735	0.00108	CcSEcCtD
Tiagabine—Rash—Fludarabine—lymphatic system cancer	0.000729	0.00107	CcSEcCtD
Tiagabine—Dermatitis—Fludarabine—lymphatic system cancer	0.000728	0.00107	CcSEcCtD
Tiagabine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000728	0.00107	CcSEcCtD
Tiagabine—Pain—Bleomycin—lymphatic system cancer	0.000725	0.00107	CcSEcCtD
Tiagabine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000724	0.00107	CcSEcCtD
Tiagabine—Headache—Fludarabine—lymphatic system cancer	0.000724	0.00107	CcSEcCtD
Tiagabine—Tachycardia—Carmustine—lymphatic system cancer	0.000722	0.00106	CcSEcCtD
Tiagabine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000717	0.00106	CcSEcCtD
Tiagabine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000717	0.00106	CcSEcCtD
Tiagabine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000717	0.00106	CcSEcCtD
Tiagabine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000715	0.00105	CcSEcCtD
Tiagabine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000709	0.00105	CcSEcCtD
Tiagabine—Oedema—Vincristine—lymphatic system cancer	0.000706	0.00104	CcSEcCtD
Tiagabine—Anorexia—Carmustine—lymphatic system cancer	0.000705	0.00104	CcSEcCtD
Tiagabine—Infection—Vincristine—lymphatic system cancer	0.000702	0.00103	CcSEcCtD
Tiagabine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000698	0.00103	CcSEcCtD
Tiagabine—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000697	0.00103	CcSEcCtD
Tiagabine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000693	0.00102	CcSEcCtD
Tiagabine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000691	0.00102	CcSEcCtD
Tiagabine—Hypotension—Carmustine—lymphatic system cancer	0.000691	0.00102	CcSEcCtD
Tiagabine—Oedema—Mitoxantrone—lymphatic system cancer	0.000688	0.00101	CcSEcCtD
Tiagabine—Nausea—Fludarabine—lymphatic system cancer	0.000687	0.00101	CcSEcCtD
Tiagabine—Infection—Mitoxantrone—lymphatic system cancer	0.000683	0.00101	CcSEcCtD
Tiagabine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000683	0.00101	CcSEcCtD
Tiagabine—Shock—Mitoxantrone—lymphatic system cancer	0.000677	0.000998	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000674	0.000994	CcSEcCtD
Tiagabine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000673	0.000993	CcSEcCtD
Tiagabine—Urticaria—Bleomycin—lymphatic system cancer	0.000673	0.000993	CcSEcCtD
Tiagabine—Anorexia—Vincristine—lymphatic system cancer	0.000673	0.000993	CcSEcCtD
Tiagabine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000671	0.00099	CcSEcCtD
Tiagabine—Body temperature increased—Bleomycin—lymphatic system cancer	0.00067	0.000988	CcSEcCtD
Tiagabine—Insomnia—Carmustine—lymphatic system cancer	0.000669	0.000987	CcSEcCtD
Tiagabine—Irritability—Methotrexate—lymphatic system cancer	0.000665	0.000981	CcSEcCtD
Tiagabine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000665	0.00098	CcSEcCtD
Tiagabine—Paraesthesia—Carmustine—lymphatic system cancer	0.000664	0.00098	CcSEcCtD
Tiagabine—Mood swings—Methotrexate—lymphatic system cancer	0.00066	0.000974	CcSEcCtD
Tiagabine—Hypotension—Vincristine—lymphatic system cancer	0.00066	0.000973	CcSEcCtD
Tiagabine—Dyspnoea—Carmustine—lymphatic system cancer	0.00066	0.000973	CcSEcCtD
Tiagabine—Somnolence—Carmustine—lymphatic system cancer	0.000658	0.00097	CcSEcCtD
Tiagabine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000656	0.000967	CcSEcCtD
Tiagabine—Ataxia—Methotrexate—lymphatic system cancer	0.000656	0.000967	CcSEcCtD
Tiagabine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000644	0.000949	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000643	0.000949	CcSEcCtD
Tiagabine—Decreased appetite—Carmustine—lymphatic system cancer	0.000643	0.000948	CcSEcCtD
Tiagabine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000643	0.000948	CcSEcCtD
Tiagabine—Insomnia—Vincristine—lymphatic system cancer	0.000639	0.000942	CcSEcCtD
Tiagabine—Paraesthesia—Vincristine—lymphatic system cancer	0.000634	0.000935	CcSEcCtD
Tiagabine—Constipation—Carmustine—lymphatic system cancer	0.000633	0.000933	CcSEcCtD
Tiagabine—Pain—Carmustine—lymphatic system cancer	0.000633	0.000933	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000627	0.000924	CcSEcCtD
Tiagabine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000624	0.000921	CcSEcCtD
Tiagabine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000618	0.000911	CcSEcCtD
Tiagabine—Decreased appetite—Vincristine—lymphatic system cancer	0.000614	0.000905	CcSEcCtD
Tiagabine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000613	0.000904	CcSEcCtD
Tiagabine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000611	0.000902	CcSEcCtD
Tiagabine—Feeling abnormal—Carmustine—lymphatic system cancer	0.00061	0.000899	CcSEcCtD
Tiagabine—Fatigue—Vincristine—lymphatic system cancer	0.000609	0.000898	CcSEcCtD
Tiagabine—Asthenia—Bleomycin—lymphatic system cancer	0.000608	0.000897	CcSEcCtD
Tiagabine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000605	0.000893	CcSEcCtD
Tiagabine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000605	0.000892	CcSEcCtD
Tiagabine—Pain—Vincristine—lymphatic system cancer	0.000604	0.000891	CcSEcCtD
Tiagabine—Constipation—Vincristine—lymphatic system cancer	0.000604	0.000891	CcSEcCtD
Tiagabine—Asthma—Methotrexate—lymphatic system cancer	0.000603	0.000889	CcSEcCtD
Tiagabine—Pruritus—Bleomycin—lymphatic system cancer	0.0006	0.000884	CcSEcCtD
Tiagabine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000598	0.000882	CcSEcCtD
Tiagabine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000593	0.000874	CcSEcCtD
Tiagabine—Constipation—Mitoxantrone—lymphatic system cancer	0.000588	0.000867	CcSEcCtD
Tiagabine—Pain—Mitoxantrone—lymphatic system cancer	0.000588	0.000867	CcSEcCtD
Tiagabine—Abdominal pain—Carmustine—lymphatic system cancer	0.000585	0.000862	CcSEcCtD
Tiagabine—Body temperature increased—Carmustine—lymphatic system cancer	0.000585	0.000862	CcSEcCtD
Tiagabine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000577	0.000852	CcSEcCtD
Tiagabine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000567	0.000836	CcSEcCtD
Tiagabine—Dysuria—Methotrexate—lymphatic system cancer	0.000563	0.000831	CcSEcCtD
Tiagabine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000562	0.000829	CcSEcCtD
Tiagabine—Body temperature increased—Vincristine—lymphatic system cancer	0.000558	0.000823	CcSEcCtD
Tiagabine—Abdominal pain—Vincristine—lymphatic system cancer	0.000558	0.000823	CcSEcCtD
Tiagabine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000555	0.000818	CcSEcCtD
Tiagabine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00055	0.000811	CcSEcCtD
Tiagabine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000546	0.000806	CcSEcCtD
Tiagabine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000545	0.000804	CcSEcCtD
Tiagabine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000544	0.000802	CcSEcCtD
Tiagabine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000544	0.000802	CcSEcCtD
Tiagabine—Pneumonia—Methotrexate—lymphatic system cancer	0.00054	0.000797	CcSEcCtD
Tiagabine—Vomiting—Bleomycin—lymphatic system cancer	0.000539	0.000795	CcSEcCtD
Tiagabine—Depression—Methotrexate—lymphatic system cancer	0.000536	0.00079	CcSEcCtD
Tiagabine—Rash—Bleomycin—lymphatic system cancer	0.000534	0.000788	CcSEcCtD
Tiagabine—Dermatitis—Bleomycin—lymphatic system cancer	0.000534	0.000787	CcSEcCtD
Tiagabine—Asthenia—Carmustine—lymphatic system cancer	0.000531	0.000783	CcSEcCtD
Tiagabine—Renal failure—Methotrexate—lymphatic system cancer	0.000528	0.000779	CcSEcCtD
Tiagabine—Stomatitis—Methotrexate—lymphatic system cancer	0.000524	0.000772	CcSEcCtD
Tiagabine—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000522	0.00077	CcSEcCtD
Tiagabine—Hypersensitivity—Vincristine—lymphatic system cancer	0.00052	0.000767	CcSEcCtD
Tiagabine—Sweating—Methotrexate—lymphatic system cancer	0.000515	0.00076	CcSEcCtD
Tiagabine—Haematuria—Methotrexate—lymphatic system cancer	0.000512	0.000755	CcSEcCtD
Tiagabine—Epistaxis—Methotrexate—lymphatic system cancer	0.000507	0.000747	CcSEcCtD
Tiagabine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000507	0.000747	CcSEcCtD
Tiagabine—Asthenia—Vincristine—lymphatic system cancer	0.000507	0.000747	CcSEcCtD
Tiagabine—Diarrhoea—Carmustine—lymphatic system cancer	0.000506	0.000746	CcSEcCtD
Tiagabine—Nausea—Bleomycin—lymphatic system cancer	0.000503	0.000742	CcSEcCtD
Tiagabine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000493	0.000728	CcSEcCtD
Tiagabine—Dizziness—Carmustine—lymphatic system cancer	0.000489	0.000721	CcSEcCtD
Tiagabine—Haemoglobin—Methotrexate—lymphatic system cancer	0.000485	0.000715	CcSEcCtD
Tiagabine—Diarrhoea—Vincristine—lymphatic system cancer	0.000483	0.000713	CcSEcCtD
Tiagabine—Haemorrhage—Methotrexate—lymphatic system cancer	0.000482	0.000711	CcSEcCtD
Tiagabine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000479	0.000706	CcSEcCtD
Tiagabine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000471	0.000694	CcSEcCtD
Tiagabine—Vomiting—Carmustine—lymphatic system cancer	0.00047	0.000694	CcSEcCtD
Tiagabine—Dizziness—Vincristine—lymphatic system cancer	0.000467	0.000689	CcSEcCtD
Tiagabine—Rash—Carmustine—lymphatic system cancer	0.000466	0.000688	CcSEcCtD
Tiagabine—Dermatitis—Carmustine—lymphatic system cancer	0.000466	0.000687	CcSEcCtD
Tiagabine—Visual impairment—Methotrexate—lymphatic system cancer	0.000465	0.000685	CcSEcCtD
Tiagabine—Headache—Carmustine—lymphatic system cancer	0.000463	0.000683	CcSEcCtD
Tiagabine—Tinnitus—Methotrexate—lymphatic system cancer	0.00045	0.000663	CcSEcCtD
Tiagabine—Vomiting—Vincristine—lymphatic system cancer	0.000449	0.000662	CcSEcCtD
Tiagabine—Rash—Vincristine—lymphatic system cancer	0.000445	0.000657	CcSEcCtD
Tiagabine—Dermatitis—Vincristine—lymphatic system cancer	0.000445	0.000656	CcSEcCtD
Tiagabine—Headache—Vincristine—lymphatic system cancer	0.000442	0.000652	CcSEcCtD
Tiagabine—Nausea—Carmustine—lymphatic system cancer	0.000439	0.000648	CcSEcCtD
Tiagabine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000437	0.000645	CcSEcCtD
Tiagabine—Rash—Mitoxantrone—lymphatic system cancer	0.000434	0.000639	CcSEcCtD
Tiagabine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000433	0.000639	CcSEcCtD
Tiagabine—Chills—Methotrexate—lymphatic system cancer	0.000433	0.000638	CcSEcCtD
Tiagabine—Headache—Mitoxantrone—lymphatic system cancer	0.000431	0.000635	CcSEcCtD
Tiagabine—Alopecia—Methotrexate—lymphatic system cancer	0.000426	0.000628	CcSEcCtD
Tiagabine—Nausea—Vincristine—lymphatic system cancer	0.000419	0.000619	CcSEcCtD
Tiagabine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000411	0.000606	CcSEcCtD
Tiagabine—Nausea—Mitoxantrone—lymphatic system cancer	0.000409	0.000602	CcSEcCtD
Tiagabine—Back pain—Methotrexate—lymphatic system cancer	0.000406	0.000599	CcSEcCtD
Tiagabine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00039	0.000574	CcSEcCtD
Tiagabine—Anaemia—Methotrexate—lymphatic system cancer	0.000388	0.000572	CcSEcCtD
Tiagabine—Malaise—Methotrexate—lymphatic system cancer	0.000379	0.000558	CcSEcCtD
Tiagabine—Vertigo—Methotrexate—lymphatic system cancer	0.000377	0.000556	CcSEcCtD
Tiagabine—Leukopenia—Methotrexate—lymphatic system cancer	0.000376	0.000554	CcSEcCtD
Tiagabine—Cough—Methotrexate—lymphatic system cancer	0.000366	0.00054	CcSEcCtD
Tiagabine—Myalgia—Methotrexate—lymphatic system cancer	0.000357	0.000527	CcSEcCtD
Tiagabine—Arthralgia—Methotrexate—lymphatic system cancer	0.000357	0.000527	CcSEcCtD
Tiagabine—Chest pain—Methotrexate—lymphatic system cancer	0.000357	0.000527	CcSEcCtD
Tiagabine—Discomfort—Methotrexate—lymphatic system cancer	0.000353	0.000521	CcSEcCtD
Tiagabine—Confusional state—Methotrexate—lymphatic system cancer	0.000346	0.000509	CcSEcCtD
Tiagabine—Infection—Methotrexate—lymphatic system cancer	0.00034	0.000502	CcSEcCtD
Tiagabine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000336	0.000495	CcSEcCtD
Tiagabine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000331	0.000488	CcSEcCtD
Tiagabine—Anorexia—Methotrexate—lymphatic system cancer	0.000327	0.000482	CcSEcCtD
Tiagabine—Hypotension—Methotrexate—lymphatic system cancer	0.00032	0.000472	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000312	0.00046	CcSEcCtD
Tiagabine—Insomnia—Methotrexate—lymphatic system cancer	0.00031	0.000457	CcSEcCtD
Tiagabine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000308	0.000454	CcSEcCtD
Tiagabine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000306	0.00045	CcSEcCtD
Tiagabine—Somnolence—Methotrexate—lymphatic system cancer	0.000305	0.000449	CcSEcCtD
Tiagabine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000302	0.000445	CcSEcCtD
Tiagabine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000298	0.000439	CcSEcCtD
Tiagabine—Fatigue—Methotrexate—lymphatic system cancer	0.000295	0.000436	CcSEcCtD
Tiagabine—Pain—Methotrexate—lymphatic system cancer	0.000293	0.000432	CcSEcCtD
Tiagabine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000282	0.000416	CcSEcCtD
Tiagabine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00028	0.000413	CcSEcCtD
Tiagabine—Urticaria—Methotrexate—lymphatic system cancer	0.000272	0.000401	CcSEcCtD
Tiagabine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000271	0.000399	CcSEcCtD
Tiagabine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000271	0.000399	CcSEcCtD
Tiagabine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000252	0.000372	CcSEcCtD
Tiagabine—Asthenia—Methotrexate—lymphatic system cancer	0.000246	0.000363	CcSEcCtD
Tiagabine—Pruritus—Methotrexate—lymphatic system cancer	0.000242	0.000357	CcSEcCtD
Tiagabine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000234	0.000346	CcSEcCtD
Tiagabine—Dizziness—Methotrexate—lymphatic system cancer	0.000227	0.000334	CcSEcCtD
Tiagabine—Vomiting—Methotrexate—lymphatic system cancer	0.000218	0.000321	CcSEcCtD
Tiagabine—Rash—Methotrexate—lymphatic system cancer	0.000216	0.000319	CcSEcCtD
Tiagabine—Dermatitis—Methotrexate—lymphatic system cancer	0.000216	0.000318	CcSEcCtD
Tiagabine—Headache—Methotrexate—lymphatic system cancer	0.000215	0.000317	CcSEcCtD
Tiagabine—Nausea—Methotrexate—lymphatic system cancer	0.000204	0.0003	CcSEcCtD
